U.S. researchers looking for genetic changes linked to autism reported on Monday an advanced gene test that searches for deleted or extra DNA in chromosomes worked three times better than standard tests.
They said the test, known as a chromosomal microarray analysis or CMA, should be used in the first round of testing done to look for a genetic cause for a child's autism.
Autism is a mysterious condition that affects as many as one in 110 U.S. children. The so-called spectrum ranges from mild Asperger's syndrome to severe mental retardation and social disability, and there is no cure or widely accepted good treatment.
Standard genetic tests to look for chromosomal abnormalities and testing for Fragile X, the single largest known genetic cause of autism, often fail to detect anything, even though genes are responsible for up to 15 percent of autism cases.
The newer chromosomal microarray analysis test is far more sensitive. It searches the whole genome for places where chromosomes have been added, are missing or are in the wrong place. But because it is not recommended for the first round of testing, some insurance companies do not cover it.
"What we're hoping is to provide evidence to make it harder for insurance companies to say we don't want to pay for this," Dr. David Miller of Children's Hospital Boston, who worked on the study published in the journal Pediatrics, said in a telephone interview.
Miller, a geneticist, said the hospital has been offering all three tests as part of a standard genetic work-up for autism since 2006.
For the study, they compared the performance of the tests done on more than 900 patients with a clinical diagnosis of autism spectrum disorder who got clinical genetic testing in 2006, 2007 and 2008.
They found that the standard test spotted genetic abnormalities in 2.23 percent of patients. Fragile X tests were abnormal in 0.46 percent of patients, while results of the CMA test turned up abnormalities in 7.3 percent of patients.
"What we showed here is what happens when you order all three of these tests up front. You end up getting more information from ordering the microarray test than from both of the two other tests combined," Miller said.
Based on the findings, the CMA test should be considered a part of the routine diagnostic evaluation for people with autism spectrum disorders, said Bai-Lin Wu, director of Children's DNA Diagnostic Lab, who led the team.
They estimated that without the CMA test, they would have missed a genetic diagnosis of autism in at least 5 percent of cases.
Miller said genetic testing helps families that already have one child diagnosed with autism assess their risk of having another child with autism. And it can help parents get early intervention for a younger sibling that might be too young for an autism diagnosis.
The worst Ebola outbreak in history has infected more than 3,000 people and killed some 1,550 since it was first detected early this year, U.S. health officials predict the number of Ebola cases will keep rising in the next two weeks.
Solar and wind's share in electricity production from renewable sources rose globally, share of hydro dropped in 2013, according to International Energy Agency report.
The fragile reef, which stretches 2,300 km (1,430 miles) along Australia's east coast was the centrepiece of a campaign by green groups and tour operators opposing the plan
World Bank President Jim Yong Kim said Western healthcare facilities would easily be able to contain the disease, and urged wealthy nations to share the knowledge and resources to help African countries tackle it.
Saudi Deputy Labor Minister Mufraj bin Saad al-Haqbani said the decision was temporary.
The World Health Organization has announced that the Ebola virus has killed some 1,552 people in West Africa, mostly in Liberia, Guinea and Sierra Leone, since the outbreak began in January.
UN deputy secretary general Jan Eliasson said the failure to address the issue of sanitation would prove “disastrous.”
The Ebola outbreak in West Africa has taken 1,552 lives out of 3,069 known cases in four countries and "continues to accelerate", WHO said
Presidential Press Secretary Jerolinmek Piah told AA the names would be announced later.
The WHO urged a range of "regulatory options", including prohibiting e-cigarette makers from making health claims
The doctor died after receiving the experimental drug ZMapp.
Japan has received inquiries from some countries on the influenza drug favipiravir, or T-705 as it is known in the developmental code.
Some 54 people have died in or near the capital Accra, and around 300 people are now being infected daily with the highly contagious disease, putting pressure on local health facilities, said Linda Van-Otoo, GHS director for Greater Accra.
A Philippine seaman is being monitored in Togo for signs of the disease but authorities say the country is still Ebola-free, despite dozens of workers returning from Liberia.
A 36-year-old man from Senegal is being tested in Barcelona.
MSF (Doctors Without Borders) has deployed 1,000 of its own staff in the stricken region, running centres that currently have 300 beds